Results 121 to 130 of about 40,837 (237)

Impact of empiric potassium supplementation on mortality, sudden cardiac arrest and stroke in furosemide initiators

British Journal of Clinical Pharmacology, Volume 92, Issue 8, Page 2924-2936, August 2026.
Aim A prior non‐randomized study suggests that potassium supplementation may improve survival among furosemide initiators, and a randomized trial suggests that salt substitutes containing potassium might lower stroke risk. We conducted a retrospective cohort study using health‐care data to confirm or refute these associations among new users of ...
Thanh Phuong Pham Nguyen, Sean Hennessy, Colleen M. Brensinger, Warren B. Bilker, Laura M. Dember, Todd A. Miano, Tat‐Thang Vo, Allison W. Willis, Charles E. Leonard   +8 more
wiley   +1 more source

The impacts of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on rates of acute kidney injury in hospitalized adults receiving multiple nephrotoxins. [PDF]

BMC Nephrol
Tabet M, Vaughan-Sarrazin M, Lund BC, Fortis S, Jalal D, Misurac J, Griffin BR.   +6 more
europepmc   +1 more source

External validation of the BAN‐ADHF diuretic‐resistance score in the DAPA‐RESIST clinical trial

British Journal of Clinical Pharmacology, Volume 92, Issue 8, Page 2960-2965, August 2026.
Diuretic resistance in worsening heart failure (HF) is associated with poorer outcomes and, although common, can be challenging to identify. The recently developed BAN‐ADHF score can potentially identify patients with worsening HF at risk of diuretic resistance.
Dominic M. Alfonso, Kieran F. Docherty, Matthew M. Y. Lee, Patrick B. Mark, Alex McConnachie, Joanna Osmanska, Bethany Stanley, Atefeh Talebi, Mark C. Petrie, John J. V. McMurray, Ross T. Campbell   +10 more
wiley   +1 more source

Angiotensin-converting enzyme inhibitors vs. receptor blockers in heart failure with mildly reduced ejection fraction. [PDF]

Front Cardiovasc Med
Weidner K, Behnes M, Reinhardt M, Abel N, Schmitt A, Lau F, Steffen HJ, Hetjens S, Duerschmied D, Akin I, Schupp T.   +10 more
europepmc   +1 more source

Superior Cardiorenal Protection With Tirzepatide Over Dulaglutide in Heart Failure With Preserved Ejection Fraction: A Large‐Scale Propensity Score–Matched Real‐World Analysis

Clinical Cardiology, Volume 49, Issue 8, August 2026.
In this large real‐world propensity‐matched analysis, tirzepatide demonstrated superior reductions in mortality, hospitalizations, and cardiorenal outcomes versus dulaglutide in HFpEF patients, with a favorable safety profile. ABSTRACT Background No direct head‐to‐head trials compare tirzepatide and dulaglutide in heart failure with preserved ejection ...
Ibrahim Khalil, Md. Imran Hossain, Mst. Mahmuda Akter, Ferdous Wahid, Aizaz Anwar Khalid, Sunjida Amin Promi, Md. Abu Sayed, Mohd Turzo Rahman, Pallab Sarker   +8 more
wiley   +1 more source

Frequency and Risk Factors for Diuretic Resistance in Patients with Decompensated Heart Failure: A Retrospective Single-Center Study in Western Mexico. [PDF]

Med Sci (Basel)
Torre-Cabrales LS, Ramírez-Ochoa S, Cervantes-Pérez G, Vicente-Hernández B, Cervantes-Guevara G, Gonzalez-Ojeda A, Fuentes-Orozco C, Hernandez-Mora FJ, Vázquez-Beltrán JC, Ambriz-Alarcón MA, Zepeda-Gutiérrez LA, Cervantes-Perez E.   +11 more
europepmc   +1 more source

Dynamic Urinary Albumin/Creatinine Ratio Patterns Predict Adverse Outcomes in HFpEF: TOPCAT Cohort Analysis

Clinical Cardiology, Volume 49, Issue 8, August 2026.
Among 746 HFpEF patients in TOPCAT, latent class modeling identified three uACR trajectories: stable, decreasing, and fluctuating high. The fluctuating high trajectory independently predicted the composite of cardiovascular death, aborted cardiac arrest, or heart failure hospitalization, and adding trajectory data modestly improved risk prediction ...
Weiping Xiao, Zhiyan Wang, Di‐en Yan, Min‐an Peng, Xinyuan Zhou   +4 more
wiley   +1 more source

ACE inhibitor-induced bradykinin-mediated angioedema presenting as small bowel obstruction and life-threatening airway angioedema: a rare dual presentation. [PDF]

BMJ Case Rep
Ghimire P, Sathya DA, Tang A, Yaqoob H.
europepmc   +1 more source

Hypertrophic Cardiomyopathy and the Risk of Bradyarrhythmia and Permanent Pacemaker Implantation: A Nationwide Cohort Study

Clinical Cardiology, Volume 49, Issue 8, August 2026.
Patients with hypertrophic cardiomyopathy had significantly higher risks of bradyarrhythmia and permanent pacemaker implantation than matched controls. Among patients with HCM, atrial fibrillation increased the risks of both outcomes, while heart failure was associated with a higher risk of permanent pacemaker implantation.
Tsu‐An Yang, Yu‐Yu Hsiao, Shang‐Ju Wu, Yu‐Shan Chien, Ming‐Jen Kuo, Yu‐Shan Huang, Guan‐Yi Li, Ching‐Heng Lin, Cheng‐Hung Li, Jiunn‐Cherng Lin, Jin‐Long Huang, Yun‐Yu Chen, Li‐Wei Lo, Yenn‐Jiang Lin, Yu‐Cheng Hsieh, Shih‐Ann Chen   +15 more
wiley   +1 more source

Impact of in-hospital ACEI use on long-term prognosis in discharged type 2 myocardial infarction patients: a retrospective propensity score-matched cohort study. [PDF]

BMC Cardiovasc Disord
Zhang JY, Liu JN, Feng WY, Luo YY, Li WL, Li Y, Wang YX, Ma XY, Ju XF, Wang F.   +9 more
europepmc   +1 more source